Be an interesting report that I have missed a link would be good as I have only:
Financial Highlights for the Nine Months of FY2020 Compared with the Nine
Months of FY2019:
• 113% increase in revenues to US$31.5 million, compared with US$14.8 million, comprising:
o 81% growth in royalty revenues to US$5.9 million from sales of TEMCELL HS Inj.®1 by
Mesoblast’s licensee for steroid-refractory acute graft versus host disease (SR-aGVHD)
in Japan, compared with US$3.3 million.
MSB Trading - 2020, page-21443
-
- There are more pages in this discussion • 1,718 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |